BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Ahmed MH, Byrne CD. Obstructive sleep apnea syndrome and fatty liver: Association or causal link? World J Gastroenterol 2010; 16(34): 4243-4252 [PMID: 20818807 DOI: 10.3748/wjg.v16.i34.4243]
URL: https://www.wjgnet.com/1007-9327/full/v16/i34/4243.htm
Number Citing Articles
1
Ayman A. Abdo, Faisal M. Sanai. Cirrhosis: A practical guide to management2015; : 301 doi: 10.1002/9781118412640.ch27
2
M. Guibert, R. Garcia. L’ODF traitement préventif du syndrome d’apnée/hypopnée de l’enfant ?Revue d'Orthopédie Dento-Faciale 2015; 49(2): 171 doi: 10.1051/odf/2015017
3
Suthat Liangpunsakul, David W. Crabb. Zakim and Boyer's Hepatology2018; : 345 doi: 10.1016/B978-0-323-37591-7.00023-9
4
Alyson Kaplan, Russell Rosenblatt. Symptom Management in Patients with Cirrhosis: a Practical GuideCurrent Treatment Options in Gastroenterology 2022; 20(2): 144 doi: 10.1007/s11938-022-00377-y
5
Pietro Vajro, Selvaggia Lenta, Piotr Socha, Anil Dhawan, Patrick McKiernan, Ulrich Baumann, Ozlem Durmaz, Florence Lacaille, Valerie McLin, Valerio Nobili. Diagnosis of Nonalcoholic Fatty Liver Disease in Children and AdolescentsJournal of Pediatric Gastroenterology and Nutrition 2012; 54(5): 700 doi: 10.1097/MPG.0b013e318252a13f
6
M. Quintero, E. Olea, S. V. Conde, A. Obeso, T. Gallego‐Martin, C. Gonzalez, J. M. Monserrat, A. Gómez‐Niño, S. Yubero, T. Agapito. Age protects from harmful effects produced by chronic intermittent hypoxiaThe Journal of Physiology 2016; 594(6): 1773 doi: 10.1113/JP270878
7
Jacob P. Christ, Kanade Shinkai, Jamie Corley, Lauri Pasch, Marcelle I. Cedars, Heather G. Huddleston. Metabolic and endocrine status associate with obstructive sleep apnea risk among patients with polycystic ovary syndromeJournal of Clinical Sleep Medicine 2024; 20(6): 871 doi: 10.5664/jcsm.11012
8
Yanlong Liu, Zhenhua Ma, Cuiqing Zhao, Yuhua Wang, Guicheng Wu, Jian Xiao, Craig J. McClain, Xiaokun Li, Wenke Feng. HIF-1α and HIF-2α are critically involved in hypoxia-induced lipid accumulation in hepatocytes through reducing PGC-1α-mediated fatty acid β-oxidationToxicology Letters 2014; 226(2): 117 doi: 10.1016/j.toxlet.2014.01.033
9
Lebing Yu, Chenli Lin, Xinhe Chen, Yuxin Teng, Shuang Zhou, Yinji Liang. A Meta-Analysis of Sleep Disorders and Nonalcoholic Fatty Liver DiseaseGastroenterology Nursing 2022; 45(5): 354 doi: 10.1097/SGA.0000000000000658
10
W. Nseir, A. Shalata, A. Marmor, N. Assy. Mechanisms Linking Nonalcoholic Fatty Liver Disease with Coronary Artery DiseaseDigestive Diseases and Sciences 2011; 56(12): 3439 doi: 10.1007/s10620-011-1767-y
11
Karthik Shree Harini, Devaraj Ezhilarasan. Wnt/beta‐catenin signaling and its modulators in nonalcoholic fatty liver diseasesHepatobiliary & Pancreatic Diseases International 2023; 22(4): 333 doi: 10.1016/j.hbpd.2022.10.003
12
Eric Dybbro, Miriam B. Vos, Rohit Kohli. Special PopulationClinics in Liver Disease 2023; 27(2): 471 doi: 10.1016/j.cld.2023.01.012
13
Oluwatobi Samuel Adegbite, Wisdom Oluwayemi Iyanda-Joe, Yetunde Ifeoma Akinsanya, Babafemi Nsikan Aka, Princessca Anulika Mogbo, Omolara Faith Yakubu, Blessing Oluwatosin Oladipo, Blessing Ariyo Afolabi, Ayobami Jahdahunsi Kukoyi, Benjamin Olusola Omiyale, Alex Emmacume Iyoha, Emmanuel Ndubuisi Maduagwu. Acetaminophen Induces Mitochondrial Permeability Transition in Rats Without Causing Necrotic Liver DamageJournal of Biological Sciences 2015; 16(1-2): 22 doi: 10.3923/jbs.2016.22.29
14
Atoosa Adibi, Majid Jaberzadeh-Ansari, Amir-Reza Dalili, Navid Omidifar, Masoumeh Sadeghi. Association between Nonalcoholic Fatty Liver Disease (NAFLD) and Coronary Artery Disease (CAD) in Patients with Angina PectorisOpen Journal of Medical Imaging 2013; 3(03): 97 doi: 10.4236/ojmi.2013.33015
15
Alita Mishra, Zobair M Younossi. Epidemiology and Natural History of Non-alcoholic Fatty Liver DiseaseJournal of Clinical and Experimental Hepatology 2012; 2(2): 135 doi: 10.1016/S0973-6883(12)60102-9
16
Cristina Oana Mărginean, Lorena Elena Meliț, Maria Oana Săsăran. Metabolic Associated Fatty Liver Disease in Children—From Atomistic to HolisticBiomedicines 2021; 9(12): 1866 doi: 10.3390/biomedicines9121866
17
Hunter S Waldman, Liliana I Renteria, Matthew J McAllister. Time-restricted feeding for the prevention of cardiometabolic diseases in high-stress occupations: a mechanistic reviewNutrition Reviews 2020; 78(6): 459 doi: 10.1093/nutrit/nuz090
18
Erik K. St. Louis. Neurological Disorders due to Systemic Disease2013; : 261 doi: 10.1002/9781118414019.ch15
19
Yuqing Cai, Jia Chen, Xiaoyu Deng, Biying Wang, Jiefeng Huang, Ningfang Lian. Triglyceride-glucose index and combined indicators: effective indicators for screening NAFLD in snoring patientsBMC Pulmonary Medicine 2024; 24(1) doi: 10.1186/s12890-024-03166-8
20
Akshay Shetty, WonKyung Cho, William Alazawi, Wing-Kin Syn. Methotrexate Hepatotoxicity and the Impact of Nonalcoholic Fatty Liver DiseaseThe American Journal of the Medical Sciences 2017; 354(2): 172 doi: 10.1016/j.amjms.2017.03.014
21
Yinghua Xu, Haiyan Wu, Xiaoling Lu. Influence of continuous positive airway pressure on lipid profiles of obstructive sleep apnea: A systematic review and meta-analysisMedicine 2022; 101(42): e31258 doi: 10.1097/MD.0000000000031258
22
Mercedes Perez-Carreras, Begoña Casis-Herce, Raquel Rivera, Inmaculada Fernandez, Pilar Martinez-Montiel, Victoria Villena. Non-alcoholic fatty liver disease in patients with intestinal, pulmonary or skin diseases: Inflammatory cross-talk that needs a multidisciplinary approachWorld Journal of Gastroenterology 2021; 27(41): 7113-7124 doi: 10.3748/wjg.v27.i41.7113
23
Niki Katsiki, Dimitri P. Mikhailidis, Christos S. Mantzoros. Non-alcoholic fatty liver disease and dyslipidemia: An updateMetabolism 2016; 65(8): 1109 doi: 10.1016/j.metabol.2016.05.003
24
Wei Sheng, Guang Ji, Li Zhang. Management of non-alcoholic fatty liver disease patients with sleep apnea syndromeWorld Journal of Gastroenterology 2022; 28(43): 6099-6108 doi: 10.3748/wjg.v28.i43.6099
25
Joi J Thomas, Jun Ren. Obstructive sleep apnoea and cardiovascular complications: perception versus knowledgeClinical and Experimental Pharmacology and Physiology 2012; 39(12): 995 doi: 10.1111/1440-1681.12024
26
Julia L. Newton, James Frith. Non‐Alcoholic Fatty Liver Disease2013; : 122 doi: 10.1002/9781118556153.ch11
27
Sarit Anavi, Zecharia Madar, Oren Tirosh. Non-alcoholic fatty liver disease, to struggle with the strangle: Oxygen availability in fatty liversRedox Biology 2017; 13: 386 doi: 10.1016/j.redox.2017.06.008
28
Julia L. Newton, David E.J. Jones. Managing systemic symptoms in chronic liver diseaseJournal of Hepatology 2012; 56: S46 doi: 10.1016/S0168-8278(12)60006-3
29
Helen L. Reeves, Marco Y. W. Zaki, Christopher P. Day. Hepatocellular Carcinoma in Obesity, Type 2 Diabetes, and NAFLDDigestive Diseases and Sciences 2016; 61(5): 1234 doi: 10.1007/s10620-016-4085-6
30
Liat Mlynarsky, Dalit Schlesinger, Roni Lotan, Muriel Webb, Zamir Halpern, Erwin Santo, Oren Shibolet, Shira Zelber-Sagi. Non-alcoholic fatty liver disease is not associated with a lower health perceptionWorld Journal of Gastroenterology 2016; 22(17): 4362-4372 doi: 10.3748/wjg.v22.i17.4362
31
T. Sangeetha, D. Kumutha, M. Divya Bharathi, R. Surendran. Smart mattress integrated with pressure sensor and IoT functions for sleep apnea detectionMeasurement: Sensors 2022; 24: 100450 doi: 10.1016/j.measen.2022.100450
32
Minbi Lee, Jihye Oh, Yoo Hyun Um, Young-Chan Kim, Tae-Won Kim, Ho Jun Seo, Jong-Hyun Jeong, Seung Chul Hong. Obstructive Sleep Apnea and Medical Comorbidities in the Asian Population: Evidence From a Nationwide Healthcare System Data in South KoreaPsychiatry Investigation 2024; 21(9): 987 doi: 10.30773/pi.2024.0045
33
Silvia Sookoian, Carlos J. Pirola. Obstructive Sleep Apnea Is Associated with Fatty Liver and Abnormal Liver Enzymes: a Meta-analysisObesity Surgery 2013; 23(11): 1815 doi: 10.1007/s11695-013-0981-4
34
Heshaam M. Mir, Maria Stepanova, Hena Afendy, Rebecca Cable, Zobair M. Younossi. Association of Sleep Disorders with Nonalcoholic Fatty Liver Disease (NAFLD): A Population-based StudyJournal of Clinical and Experimental Hepatology 2013; 3(3): 181 doi: 10.1016/j.jceh.2013.06.004
35
Said O. Muhidin, Ahmed A. Magan, Khalid A. Osman, Shareef Syed, Mohamed H. Ahmed. The Relationship between Nonalcoholic Fatty Liver Disease and Colorectal Cancer: The Future Challenges and Outcomes of the Metabolic SyndromeJournal of Obesity 2012; 2012: 1 doi: 10.1155/2012/637538
36
Marta Stelmach-Mardas, Marcin Mardas, Khalid Iqbal, Magdalena Kostrzewska, Tomasz Piorunek. Dietary and cardio-metabolic risk factors in patients with Obstructive Sleep Apnea: cross-sectional studyPeerJ 2017; 5: e3259 doi: 10.7717/peerj.3259
37
Yu-Tsung Chou, Hsiang-Ju Cheng, Jin-Shang Wu, Yi-Ching Yang, Chieh-Ying Chou, Chih-Jen Chang, Feng-Hwa Lu. The association of sleep duration and sleep quality with non-alcoholic fatty liver disease in a Taiwanese populationObesity Research & Clinical Practice 2018; 12(6): 500 doi: 10.1016/j.orcp.2018.05.002
38
Marta Stelmach-Mardas, Paweł Bogdański, Marcin Mardas, Monika Szulinska, Jarosław Walkowiak, Tomasz Piorunek. L-carnitine for reducing cardio-metabolic risk in patients with obstructive sleep apnea: study protocol of a randomized, double-blind, placebo-controlled trialClinical and Translational Degenerative Diseases 2016; 1(3): 134 doi: 10.4103/2468-5658.191356
39
Soumya Kurnool, Karen C. McCowen, Nicole A. Bernstein, Atul Malhotra. Sleep Apnea, Obesity, and Diabetes — an Intertwined TrioCurrent Diabetes Reports 2023; 23(7): 165 doi: 10.1007/s11892-023-01510-6
40
Anna F. Sheptulina, Ekaterina O. Lyusina, Elvira M. Mamutova, Adel A. Yafarova, Anton R. Kiselev, Oxana M. Drapkina. Bioelectrical Impedance Analysis Demonstrates Reliable Agreement with Dual-Energy X-ray Absorptiometry in Identifying Reduced Skeletal Muscle Mass in Patients with Metabolic Dysfunction-Associated Steatotic Liver Disease and HypertensionDiagnostics 2024; 14(20): 2301 doi: 10.3390/diagnostics14202301
41
Michael S. Kostapanos, Moses S. Elisaf, Dimitri P. Mikhailidis. Obstructive Sleep Apnea and Cardiovascular RiskAngiology 2012; 63(8): 569 doi: 10.1177/0003319711436077
42
Mauricio de Sant Anna Junior, Jose Egidio Paulo de Oliveira, João Regis Ivar Carneiro, Fernando Silva Guimarães, Diego de Faria Magalhães Torres, Adalgiza Mafra Moreno, José Fernandes Filho, Renata Carvalhal. Força muscular respiratória de mulheres obesas mórbidas e eutróficasFisioterapia e Pesquisa 2011; 18(2): 122 doi: 10.1590/S1809-29502011000200004
43
Mohamed H. Ahmed, Salma Barakat, Ahmed O. Almobarak. Nonalcoholic Fatty Liver Disease and Cardiovascular Disease: Has the Time Come for Cardiologists to Be Hepatologists?Journal of Obesity 2012; 2012: 1 doi: 10.1155/2012/483135
44
Amal Abd El-Azeem I., Mohamed A. Saraya. The effect of chronic intermittent hypoxia in the evolution of NASHEgyptian Journal of Chest Diseases and Tuberculosis 2012; 61(3): 197 doi: 10.1016/j.ejcdt.2012.10.027
45
Mary Sau-Man Ip. Principles and Practice of Sleep Medicine2017; : 1167 doi: 10.1016/B978-0-323-24288-2.00118-5
46
Surya Prakash Bhatt, Randeep Guleria. Sleep apnea and fatty liver disease: The growing link and management issuesWorld Journal of Respirology 2014; 4(2): 11-18 doi: 10.5320/wjr.v4.i2.11
47
Akshay Shetty, Jennifer W. Hsu, Paul P. Manka, Wing-Kin Syn. Role of the Circadian Clock in the Metabolic Syndrome and Nonalcoholic Fatty Liver DiseaseDigestive Diseases and Sciences 2018; 63(12): 3187 doi: 10.1007/s10620-018-5242-x
48
Stefano Ballestri, Alessandro Mantovani, Fabio Nascimbeni, Simonetta Lugari, Amedeo Lonardo. Extra-Hepatic Manifestations and Complications of Nonalcoholic Fatty Liver DiseaseFuture Medicinal Chemistry 2019; 11(16): 2171 doi: 10.4155/fmc-2019-0003
49
Hsu-Han Su, Fung-Chang Sung, Kai-Liang Kao, Shu-Chin Chen, Chen-Ju Lin, Shu-I Wu, Cheng-Li Lin, Robert Stewart, Yi-Shin Chen. Relative risk of functional dyspepsia in patients with sleep disturbance: a population-based cohort studyScientific Reports 2021; 11(1) doi: 10.1038/s41598-021-98169-4
50
M.R. Bonsignore, W.T. McNicholas, J.M. Montserrat, J. Eckel. Adipose tissue in obesity and obstructive sleep apnoeaEuropean Respiratory Journal 2012; 39(3): 746 doi: 10.1183/09031936.00047010
51
Gyongyi Szabo, Timea Csak. Role of MicroRNAs in NAFLD/NASHDigestive Diseases and Sciences 2016; 61(5): 1314 doi: 10.1007/s10620-015-4002-4
52
Richie Manikat, Mindie H. Nguyen. Nonalcoholic fatty liver disease and non-liver comorbiditiesClinical and Molecular Hepatology 2023; 29(Suppl): s86 doi: 10.3350/cmh.2022.0442